Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

RECRUITING

Cohort SURVI : Intestinal Ischemia and Vascular Diseases

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Mesenteric Ischemia

Eligibility:

All Genders

18+ years

Brief Summary

The first Intestinal Vascular Emergency Unit (SURVI), with the institutional support of AP-HP, opened on 4 January 2016, within the Paris-Nord Val de Seine University Hospital Group. This intensive ca...

Detailed Description

The first Intestinal Vascular Emergency Unit (SURVI), with the institutional support of AP-HP, opened on 4 January 2016, within the Paris-Nord Val de Seine University Hospital Group. This intensive ca...

Eligibility Criteria

Inclusion

  • Age \> 18 years old
  • IMVI including :
  • acute mesenteric ischaemia defined by acute digestive distress in relation to arterial and/or venous, occlusive and/or non-occlusive splanchnic-mesenteric vascular insufficiency, in the absence of an alternative diagnosis
  • Chronic mesenteric ischaemia defined by chronic digestive distress (duration of symptom evolution \>30 days) related to occlusive or non- occlusive arterial or venous vascular insufficiency.
  • MVI: gastrointestinal arterial or venous diseases without ischaemia (atheroma, embolism, thrombosis, dissection, mediolysis, aneurysm, dysplasia, sheathing, compression, torsion)

Exclusion

  • Left ischaemic colitis without damage to the celiac trunk and/or superior mesenteric artery
  • Dissection of the abdominal aorta without intestinal ischaemia
  • Portal thrombosis without extension to the superior mesenteric vein
  • Portal thrombosis without extension to the superior mesenteric vein
  • Traumatic rupture of the digestive arteries
  • Non-injected abdominal scanner or no abdominal scanner
  • Patient opposition to participation in research
  • Patient under guardianship / curators
  • Vulnerable patient: pregnant or breastfeeding women, persons deprived of their liberty, minors, adults unable or unwilling to give consent

Key Trial Info

Start Date :

November 27 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 4 2041

Estimated Enrollment :

20000 Patients enrolled

Trial Details

Trial ID

NCT04746534

Start Date

November 27 2020

End Date

January 4 2041

Last Update

February 9 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Olivier CORCOS

Clichy, France, 92110